Common Contracts

12 similar Placement Agency Agreement contracts by ShiftPixy, Inc., Virpax Pharmaceuticals, Inc., Tenon Medical, Inc., others

Placement Agency Agreement
Placement Agency Agreement • November 1st, 2024 • Lixte Biotechnology Holdings, Inc. • Pharmaceutical preparations • New York
AutoNDA by SimpleDocs
Placement Agency Agreement
Placement Agency Agreement • October 31st, 2024 • Palladyne AI Corp. • Services-prepackaged software • New York
Placement Agency Agreement
Placement Agency Agreement • September 23rd, 2024 • Fortress Biotech, Inc. • Pharmaceutical preparations • New York
Placement Agency Agreement
Placement Agency Agreement • September 17th, 2024 • Tenon Medical, Inc. • Surgical & medical instruments & apparatus • New York
Placement Agency Agreement
Placement Agency Agreement • September 9th, 2024 • Tenon Medical, Inc. • Surgical & medical instruments & apparatus • New York
PLACEMENT AGENCY AGREEMENT
Placement Agency Agreement • August 27th, 2024 • ShiftPixy, Inc. • Services-employment agencies • New York
PLACEMENT AGENCY AGREEMENT
Placement Agency Agreement • August 20th, 2024 • ShiftPixy, Inc. • Services-employment agencies • New York
PLACEMENT AGENCY AGREEMENT
Placement Agency Agreement • July 30th, 2024 • ShiftPixy, Inc. • Services-employment agencies • New York
Placement Agency Agreement
Placement Agency Agreement • May 17th, 2024 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Placement Agency Agreement
Placement Agency Agreement • May 13th, 2024 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Placement Agency Agreement
Placement Agency Agreement • April 18th, 2024 • Virpax Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
PLACEMENT AGENCY AGREEMENT
Placement Agency Agreement • January 26th, 2024 • Aspira Women's Health Inc. • In vitro & in vivo diagnostic substances • New York

This letter (the “Agreement”) constitutes the agreement between A.G.P./Alliance Global Partners (the “Placement Agent”) and Aspira Women’s Health Inc., a Delaware corporation (the “Company”), that the Placement Agent shall serve as the exclusive placement agent for the Company, on a reasonable “best efforts” basis, in connection with the proposed offering (the “Placement”) of (i) shares (the “Shares”) of common stock of the Company, par value $0.001 per share (the “Common Stock”), warrants to purchase share of Common Stock (the “Common Warrants”) and (iii) pre-funded warrants to purchase Shares (the “Pre-Funded Warrants” and together with the Shares and Common Warrants, the “Securities”). The Securities actually placed by the Placement Agent are referred to herein as the “Placement Securities.” The Shares, Pre-Funded Warrants, and the shares of Common Stock underlying the Pre-Funded Warrants will be offered and sold under the Company’s registration statement on Form S-3 (File No. 333-2

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!